ISRG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Intuitive Surgical Inc (ISRG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive growth trends, and favorable industry tailwinds outweigh the minor negative catalysts. While there are no proprietary trading signals today, the stock's fundamentals and long-term potential make it a solid investment opportunity.
The MACD is positively expanding with a histogram of 3.508, indicating bullish momentum. RSI is at 60.975, which is neutral but leaning towards bullish. The stock is trading near a resistance level (R1: 484.584), and moving averages are converging, suggesting potential upward momentum.
Strong Q1 financial performance with revenue up 22.96% YoY, net income up 17.63% YoY, and EPS up 18.75% YoY.
Positive industry tailwinds from an aging global population driving demand for healthcare technology.
Analysts highlight the company's competitive advantages, including its installed base of da Vinci surgical robots, which grew by 12% YoY.
Insider selling has increased by 184% over the last month, which could indicate some caution from internal stakeholders.
Analysts have recently lowered price targets, although most maintain positive ratings.
Hedge funds remain neutral, showing no significant trading trends.
In Q1 2026, Intuitive Surgical reported strong financial growth: revenue increased by 22.96% YoY to $2.77 billion, net income rose by 17.63% YoY to $821.5 million, and EPS grew by 18.75% YoY to 2.28. Gross margin also improved to 66.06%, up 2.12% YoY, reflecting operational efficiency.
Analyst sentiment is mixed but leans positive. Barclays, Baird, and Piper Sandler highlight strong Q1 performance and maintain Overweight or Outperform ratings, though price targets have been adjusted downward. The consensus reflects confidence in the company's long-term growth potential despite short-term caution in the MedTech sector.
